Milos Pesek Selected Research

Milos Pesek Research Topics

Disease

36	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 09/2003
15	Neoplasms (Cancer) 01/2022 - 01/2009
6	Lung Neoplasms (Lung Cancer) 06/2020 - 04/2007
4	Adenocarcinoma 08/2020 - 07/2009
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2020 - 11/2011
4	Exanthema (Rash) 11/2017 - 04/2007
3	Inflammation (Inflammations) 12/2018 - 06/2004
2	Residual Neoplasm 01/2022 - 11/2012
2	Diarrhea 01/2016 - 04/2007
2	Sarcoma (Soft Tissue Sarcoma) 08/2015 - 04/2013
2	Pleural Effusion (Pleural Effusions) 01/2010 - 06/2004
1	Thymoma (Thymic Carcinoma) 11/2020
1	Carcinoma (Carcinomatosis) 08/2020
1	Fatigue 01/2016
1	Hyponatremia 12/2014
1	Adenocarcinoma of Lung 08/2013
1	Breast Neoplasms (Breast Cancer) 11/2012
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 12/2011
1	Wilms Tumor (Wilm's Tumor) 12/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2010
1	Disease Progression 04/2007

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 08/2020 - 08/2010
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2020 - 04/2007
8	Tyrosine Kinase InhibitorsIBA 11/2017 - 05/2010
6	Pemetrexed (MTA)FDA Link 05/2021 - 08/2013
5	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2013
4	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 06/2014
4	Bevacizumab (Avastin)FDA Link 05/2021 - 03/2020
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2022 - 07/2018
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 07/2009
3	Messenger RNA (mRNA)IBA 12/2017 - 11/2011
3	Gefitinib (Iressa)FDA Link 08/2015 - 09/2008
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2021
2	Circulating Tumor DNAIBA 01/2023 - 01/2022
2	AlbuminsIBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2003
2	Thyroid Nuclear Factor 1IBA 08/2020 - 02/2017
2	IodineIBA 06/2020 - 07/2018
2	Folic Acid AntagonistsIBA 01/2020 - 02/2017
2	thiamine triphosphorate (TTP)IBA 07/2009 - 04/2007
2	Gemcitabine FDA Link 04/2007 - 09/2003
2	Cisplatin (Platino)FDA LinkGeneric 04/2007 - 09/2003
1	C-Reactive ProteinIBA 01/2023
1	antigen CYFRA21.1IBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Keratin-19 (Keratin 19)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2022
1	PlatinumIBA 05/2021
1	SodiumIBA 01/2021
1	S-1,2-dichlorovinyl-N-acetylcysteineIBA 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	Fluorine-18IBA 06/2020
1	nintedanibIBA 03/2020
1	CrizotinibIBA 03/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	NivolumabIBA 12/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Thymidylate SynthaseIBA 12/2017
1	Cytostatic AgentsIBA 02/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2012
1	Adenomatous Polyposis Coli ProteinIBA 12/2011
1	PAX6 Transcription FactorIBA 12/2011
1	Proteins (Proteins, Gene)FDA Link 12/2011
1	Estrogen ReceptorsIBA 12/2011
1	Cell Adhesion MoleculesIBA 12/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2011
1	WT1 ProteinsIBA 12/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2011
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2011
1	Vitamin D FDA LinkGeneric 10/2011
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2010
1	N 30IBA 01/2010
1	Codon (Codons)IBA 07/2009
1	cathepsin SIBA 01/2009
1	Cathepsin HIBA 01/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2008
1	Docetaxel (Taxotere)FDA Link 09/2007
1	vandetanib (ZD6474)IBA 09/2007
1	pro-matrix metalloproteinase 9IBA 06/2004
1	Enzyme Precursors (Zymogens)IBA 06/2004
1	Talc FDA Link 06/2004

Therapy/Procedure

10	Therapeutics 03/2022 - 07/2009
9	Drug Therapy (Chemotherapy) 05/2021 - 04/2007
2	Immunotherapy 01/2021 - 01/2020
2	Adjuvant Chemotherapy 12/2017 - 11/2012
2	Biological Therapy 10/2010 - 08/2010
1	Secondary Prevention 06/2020
1	Combination Drug Therapy (Combination Chemotherapy) 03/2020
1	Palliative Care (Palliative Therapy) 01/2018
1	Molecular Targeted Therapy 01/2013